Selective Estrogen Receptor Modulators [horm, phsu]
Special [qlco]
Focus [spco]
effects [qlco]
coronary heart disease [dsyn]
postmenopausal [tmco]
Women [popg]
Menopause [phsf]
age onset [qnco]
Associated [qlco]
Marked [qlco]
Increase [ftcn]
Coronary heart disease risk [inpr]
Epidemiological Studies [resa]
effects [qlco]
postmenopausal [tmco]
Hormone Therapy [topp]
coronary heart disease [dsyn]
Markers, Risk [qlco]
Suggest [idcn]
coronary heart disease [dsyn]
PREVENT [phsu]
postmenopausal [tmco]
Women [popg]
Long-term [tmco]
Hormone Therapy [topp]
Publications [inpr, mnob]
Heart [bpoc]
Estrogen Replacement [topp]
Progestin [horm, phsu, strd]
Study [mnob]
Initiative [menp]
Trial [resa]
Prescription [hlca]
Hormone Therapy [topp]
Prevention [topp]
controversies [socb]
Major [qlco]
Effort [orgf]
Make [ftcn]
To [qlco]
Alternative [cnce]
Hormone Therapy [topp]
Compound [qlco]
Suggest [idcn]
included [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
Represent [acty]
Class [inpr]
Compound [qlco]
ACT [topp]
Estrogen Receptor Agonists [moft]
antagonists [chvf]
Tissue specific [bdsu]
This [euka]
Pharmacological [bmod]
Profile [lbpr]
Favorable [qlco]
Estrogenic Effects [fndg]
Bone [bpoc]
Cardiovascular system [bdsy]
Unfavorable [qlco]
effects [qlco]
Breast [bpoc]
Endometrium [bpoc]
Two [qnco]
Suggest [idcn]
included [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
presently [idcn]
Market [geoa]
Tamoxifen [orch, phsu]
Raloxifene [orch, phsu]
Only [qnco]
Data [idcn]
Available [ftcn]
effects [qlco]
Tamoxifen [orch, phsu]
cardiovascular events [fndg]
postmenopausal [tmco]
Women [popg]
Breast Cancer [neop]
Trial [resa]
Trial [resa]
Found [qnco]
Few [qnco]
Fatal [qlco]
Myocardial [spco]
Events [evnt]
Women [popg]
Assigned [ftcn]
Tamoxifen [orch, phsu]
Compared [acty]
Women [popg]
Assigned [ftcn]
placebo [topp]
Raloxifene [orch, phsu]
Second [qnco]
Generation [tmco]
SERM [horm, phsu]
Show [inpr]
To [qlco]
PREVENT [phsu]
Osteoporotic Fractures [dsyn]
Endometrium [bpoc]
Hold [idcn]
High [qlco]
promise [idcn]
Prevention [topp]
Breast Cancer [neop]
Effect [qlco]
Raloxifene [orch, phsu]
Uncertain [idcn]
More [ftcn]
Multiple [qnco]
Outcome [ftcn]
Raloxifene [orch, phsu]
Evaluation [ftcn]
Trial [resa]
Raloxifene [orch, phsu]
Protection [fndg]
Women [popg]
coronary heart disease [dsyn]
High Risk [qlco]
Raloxifene [orch, phsu]
Risk [qlco]
coronary heart disease [dsyn]
Clinical Trial [resa]
Hard [qlco]
Clinical Endpoint [clna]
Study [mnob]
Currently [tmco]
Generation [tmco]
Suggest [idcn]
included [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
Taken [cnce]
Clinical [qlco]
development [phsf]
idoxifene [orch, phsu]
droloxifene [orch, phsu]
Ospemifene [orch, phsu]
arzoxifene [orch, phsu]
Acolbifene [orch]
levormeloxifene [orch, phsu]
Lasofoxifene [orch, phsu]
bazedoxifene [orch, phsu]
Aim [idcn]
To [qlco]
Find [fndg]
Compound [qlco]
Ideal [qlco]
Profile [lbpr]
Climacteric [orgf]
symptoms [ftcn]
Prevention [topp]
Osteoporotic Fractures [dsyn]
Adverse Effect [fndg]
Oil [lipd]
Breast [bpoc]
Endometrium [bpoc]
Negative [qlco]
Effect [qlco]
Effect [qlco]
Oil [lipd]
Cardiovascular system [bdsy]
Brain [bpoc]
Currently [tmco]
Limited [ftcn]
Data [idcn]
Available [ftcn]
Generation [tmco]
Suggest [idcn]
included [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
coronary heart disease [dsyn]
Novel [tmco]
Agent [chvf]
Provide [acty]
arguments [socb]
Continuing [idcn]
search [inpr]
Ideal [qlco]
SERM [horm, phsu]
